Velmanase alfa

N/A

Report date: 2023/03/09 16:08:27
First In Class

Base Information

Drug NameVelmanase alfa
Drug Alias Namevelmanasa alfa维马酶α维尔玛酶αRecombinant lysosomal alpha-mannosidaserhLAMAN +[13
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionAlpha-mannosidase replacements
TargetsMannose
Therapy Area/Indicationsalpha-Mannosidosis
Global Approved Indicationsalpha-Mannosidosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2018/03/23
Country/TerritoryBelgiumUnited StatesPoland +[11
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesZymenex As
China Registration ClassN/A

Develop Information

Active CompaniesChiesi Farmaceutici SPA
Inactive CompaniesZymenex As
Active Indicationsalpha-Mannosidosis
Inactive IndicationsN/A

Other Information

ATC CodeA16AB15
Related LinksN/A